Cullinan Oncology Common
(CGEM)
|
23.2 |
$98M |
|
7.6M |
12.82 |
iTeos Therapeutics Common
(ITOS)
|
7.9 |
$33M |
|
1.7M |
19.05 |
Inhibrx Common
|
5.4 |
$23M |
|
1.3M |
17.95 |
Verve Therapeutics Common
(VERV)
|
5.2 |
$22M |
|
636k |
34.35 |
Intellia Therapeutics Common
(NTLA)
|
5.0 |
$21M |
|
374k |
55.96 |
Repare Therapeutics Common
(RPTX)
|
4.7 |
$20M |
|
1.6M |
12.13 |
Geron Corporation Common
(GERN)
|
4.7 |
$20M |
|
8.4M |
2.34 |
Iveric Bio Common
|
4.5 |
$19M |
|
1.1M |
17.94 |
Merus Common
(MRUS)
|
4.4 |
$18M |
|
918k |
20.03 |
Regenxbio Common
(RGNX)
|
3.9 |
$16M |
|
619k |
26.43 |
Iovance Biotherapeutics Common
(IOVA)
|
3.9 |
$16M |
|
1.7M |
9.58 |
Werewolf Therapeutics Common
(HOWL)
|
2.6 |
$11M |
|
2.4M |
4.51 |
G1 Therapeutics Common
|
2.5 |
$11M |
|
857k |
12.49 |
Cytokinetics Common
(CYTK)
|
2.2 |
$9.4M |
|
193k |
48.45 |
Biocryst Pharmaceuticals Common
(BCRX)
|
1.8 |
$7.6M |
|
606k |
12.60 |
Crinetics Pharmaceuticals Common
(CRNX)
|
1.7 |
$7.2M |
|
365k |
19.64 |
Travere Therapeutics Common
(TVTX)
|
1.6 |
$6.8M |
|
277k |
24.64 |
Y Mabs Therapeutics Common
(YMAB)
|
1.5 |
$6.4M |
|
444k |
14.42 |
TCR2 Therapeutics Common
|
1.4 |
$6.1M |
|
3.4M |
1.80 |
Harmony Biosciences Hldgs Common
(HRMY)
|
1.4 |
$6.1M |
|
137k |
44.29 |
Arcutis Biotherapeutics Common
(ARQT)
|
1.2 |
$4.9M |
|
257k |
19.11 |
Reata Pharmaceuticals Common
|
1.1 |
$4.5M |
|
179k |
25.13 |
Amicus Therapeutics Common
(FOLD)
|
1.0 |
$4.1M |
|
393k |
10.44 |
Provention Bio Common
|
0.8 |
$3.3M |
|
740k |
4.50 |
Harpoon Therapeutics Common
|
0.7 |
$3.1M |
|
3.2M |
0.97 |
Edgewise Therapeutics Common
(EWTX)
|
0.7 |
$3.0M |
|
304k |
9.84 |
Madrigal Pharmaceuticals Common
(MDGL)
|
0.7 |
$2.9M |
|
45k |
64.99 |
Revolution Medicines Common
(RVMD)
|
0.7 |
$2.9M |
|
146k |
19.72 |
Verastem Common
|
0.7 |
$2.8M |
|
3.2M |
0.85 |
Phathom Pharmaceuticals Common
(PHAT)
|
0.5 |
$2.1M |
|
193k |
11.08 |
Avadel Pharmaceuticals Common
|
0.5 |
$2.1M |
|
412k |
5.01 |
Mirum Pharmaceuticals Common
(MIRM)
|
0.5 |
$2.0M |
|
97k |
21.01 |
Oncorus Common
|
0.5 |
$2.0M |
|
2.4M |
0.85 |
Inozyme Pharma Common
(INZY)
|
0.4 |
$1.8M |
|
661k |
2.68 |
ADC Therapeutics Common
(ADCT)
|
0.4 |
$1.6M |
|
334k |
4.82 |
ESSA Pharma Common
(EPIX)
|
0.2 |
$738k |
|
406k |
1.82 |
Avrobio Common
(AVRO)
|
0.1 |
$416k |
|
648k |
0.64 |
Black Diamond Therapeutics Common
(BDTX)
|
0.1 |
$405k |
|
240k |
1.69 |